(MedPage Today) -- For years, healthcare organizations have sounded the alarm about clinician burnout. Conferences convene around it, task forces study it, and wellness programs promise to fix it. From mindfulness apps to resilience training to...
(MedPage Today) -- The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing for September to discuss potential therapeutic uses. Meanwhile, HHS and the VA are partnering to speed up the research and development...
(MedPage Today) -- Children born during England's COVID lockdown appeared to have markedly lower executive function than expected for their age, interim results of a cross-sectional observational study showed. Among more than 200 4-year-olds born...
(MedPage Today) -- Epidural analgesia in labor was not linked to adverse neonatal neurological outcomes, a Scottish cohort study found. An analysis of nearly half a million deliveries found no association between epidural analgesia in labor and...
(MedPage Today) -- Nominees for the positions of CDC director and assistant secretary for preparedness and response (ASPR) faced tricky questions and some frustration Wednesday from senators on both sides of the aisle. Sen. Bill Cassidy, MD (R...
(MedPage Today) -- It was feasible to take x-rays in space, potentially improving diagnostic capabilities for crew health, according to a small prospective study. Using a portable radiography system, three crew members on the 3.5-day Fram2 polar...
(MedPage Today) -- Americans were less likely to have a healthcare-associated infection (HAI) in 2023 than in 2015, though reducing surgical-site infections and non-ventilator-associated pneumonia in hospitals remained a challenge, CDC survey findings...
(MedPage Today) -- Among people undergoing coronary angiography for suspected coronary artery disease (CAD), heart attack patients stood out for having higher microplastics and nanoplastics in their blood, a small Italian study found. People with...
(MedPage Today) -- Very high levels of plasma phosphorylated tau 217 (p-tau217), a marker of amyloid burden in the brain, predicted future risk of cognitive impairment among older adults who were initially unimpaired, a multicohort study suggested...
(MedPage Today) -- Maintenance therapy with continuous lenalidomide (Revlimid) did not significantly improve overall survival (OS) in patients with standard-risk, newly diagnosed multiple myeloma, the phase III ENDURANCE trial showed. Among patients...
(MedPage Today) -- Under a cloudless sky, shrieks of youthful joy pierced the air as a kite took flight. Two children sang as they turned the rope for their jumping companion, smiling when younger ones interrupted the game in pursuit of a runaway...